- AAPS to Oversee Scientific Programming for INTERPHEX
- Attendees of National Biotechnology Conference can register for INTERPHEX free of charge
RX has selected AAPS to serve as the exclusive authority on scientific focus areas that affect INTERPHEX, the approximate 8,000-person event, beginning in spring 2023 under a new agreement. AAPS will play a key role in reviewing and selecting programming for the event, particularly in areas focused on the intersection of business and science.
The first benefit scientists and members of AAPS will see from this collaboration, however, is a great deal: Registrants of AAPS’ National Biotechnology Conference (NBC) can attend INTERPHEX free of charge this year.
Prior to the INTERPHEX meeting, scheduled for April 25-27 at the Javits Center in New York City, AAPS will host the National Biotechnology Conference (NBC), April 23-26, in Philadelphia, PA, featuring the latest research in cell and gene therapy. NBC registrants will receive a custom link to access INTERPHEX upon completing a full-conference registration.
AAPS, a non-profit, professional society of 7,000 pharmaceutical scientists, is focused on raising the bar for science across the pharmaceutical industry. Through this new agreement, the organization will share its expertise with INTERPHEX, an event that brings together business leaders and scientists from across the commercial contracting space.
“This is an important step for us in pursuing our mission of bringing scientists together to advance cures and therapies that will help patients around the world,” AAPS President Patrick Sinko, Ph.D., said. “We are going to support RX in creating a scientific experience at INTERPHEX that helps industry professionals look into the future while solving today’s problems.”
“The collaboration with AAPS is an important next chapter for INTERPHEX,” Marie Brown, Group Vice President at RX, said. “INTERPHEX has traditionally been an event primarily focused on product discovery and finding solutions to effectively develop and manufacture quality products. We are excited that AAPS will elevate and expand the content to attract and satisfy the educational needs of research scientists and provide that important link between science and commercialization.”
For more information about NBC or to register, visit https://www.eventscribe.net/2023/NBC/.
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org
The National Biotechnology Conference (NBC) brings together scientists from around the world and across disciplines to discuss the latest research and insights in biotechnology, including gene editing, cell therapies, CAR-T, the latest in immunogenicity, and other topics critical to advancing the science tackling today’s most challenging diseases. The NBC seeks to drive conversations that lead to unique collaborations by testing the conventional wisdom in biotechnology.
INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” The event is based in New York and brings approximately 8,000 global industry professionals and industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency, and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies. and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. INTERPHEX continues the learning beyond the show floor. For more information, visit www.INTERPHEX.com.
RX is in the business of building businesses for individuals, communities, and organizations. We elevate the power of face-to-face events by combining data and digital products to help customers learn about markets, source products, and complete transactions at over 400 events in 22 countries and regions across 43 industry sectors. RX is passionate about making a positive impact on society and is fully committed to creating an inclusive work environment for all our people. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.rxglobal.com